Tony Bruns
Overview
Explore the profile of Tony Bruns including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
144
Citations
2024
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Patidar K, Ma A, Juanola A, Barone A, Incicco S, Kulkarni A, et al.
Lancet Gastroenterol Hepatol
. 2025 Mar;
PMID: 40058397
Background: Acute kidney injury (AKI) is a serious complication of cirrhosis. A systematic, global characterisation of AKI occurring in patients with cirrhosis is lacking. We therefore aimed to assess global...
2.
Haedge F, Bruns T
Expert Rev Gastroenterol Hepatol
. 2025 Feb;
19(2):111-130.
PMID: 39921440
Introduction: Bacterial infections are a leading cause of hospitalization and mortality in patients with decompensated cirrhosis. Antibiotic prophylaxis in cirrhotic patients has demonstrated significant short-term reductions in bacterial infections in...
3.
Sturm L, Schultheiss M, Stohr F, Labenz C, Maasoumy B, Tiede A, et al.
J Hepatol
. 2025 Feb;
PMID: 39914747
Background & Aims: The Freiburg Index of Post-TIPS Survival (FIPS) defines a high-risk group of patients with significantly reduced survival following transjugular intrahepatic portosystemic shunt (TIPS) implantation. However, the clinical...
4.
Xiong L, Beyer D, Liu N, Lehmann T, Neugebauer S, Schaeuble S, et al.
Pharmacol Res
. 2025 Jan;
212:107581.
PMID: 39761839
Sepsis is a life-threatening organ failure resulting from a poorly regulated infection response. Organ dysfunction includes hepatic involvement, weakening the immune system due to excretory liver failure, and metabolic dysfunction,...
5.
Pollmanns M, Kister B, Abu Jhaisha S, Adams J, Kabak E, Brozat J, et al.
Sci Rep
. 2024 Dec;
14(1):30497.
PMID: 39681633
Acute-on-chronic liver failure (ACLF) defines a heterogeneous syndrome involving acute decompensation in patients with pre-existing liver disease accompanied by (multi-)organ failure. This study aimed to develop a simple, reliable machine...
6.
Fromme M, Payance A, Mandorfer M, Thorhauge K, Pons M, Miravitlles M, et al.
Gastroenterology
. 2024 Oct;
168(2):367-381.
PMID: 39414159
Background & Aims: Homozygous Pi∗Z mutation in alpha-1 antitrypsin (Pi∗ZZ genotype) predisposes to pulmonary loss-of-function and hepatic gain-of-function injury. To facilitate selection into clinical trials typically targeting only 1 organ,...
7.
Roberts S, Choi W, Worobetz L, Vincent C, Flemming J, Cheung A, et al.
JHEP Rep
. 2024 Oct;
6(10):101168.
PMID: 39380718
Background & Aims: Biochemical response to ursodeoxycholic acid (UDCA) therapy is associated with good prognosis in people living with primary biliary cholangitis (PBC). Biochemical response is typically assessed early in...
8.
Berg T, Aehling N, Bruns T, Welker M, Weismuller T, Trebicka J, et al.
Z Gastroenterol
. 2024 Sep;
62(9):1397-1573.
PMID: 39250961
No abstract available.
9.
Lorenz P, Aehling N, Bruns T, Bechstein W, Becker T, Berg T, et al.
Z Gastroenterol
. 2024 Sep;
62(9):e537-e554.
PMID: 39250959
No abstract available.
10.
Lam L, Soret P, Lemoinne S, Hansen B, Hirschfield G, Gulamhusein A, et al.
Clin Gastroenterol Hepatol
. 2024 Jul;
22(12):2432-2441.e2.
PMID: 39019421
Background & Aims: In primary biliary cholangitis (PBC), static liver stiffness measurement (LSM) has proven prognostic value. However, the added prognostic value of LSM time course in this disease remains...